Multi-center feasibility study of anastomotic leakage for right-sided colon cancer focusing on laparoscopic intracorporeal overlap reconstruction

Multi-center feasibility study of anastomotic leakage for right-sided colon cancer focusing on laparoscopic intracorporeal overlap reconstruction - Multi-center feasibility study of anastomotic leakage for right-sided colon cancer focusing on laparoscopic intracorporeal overlap reconstruction

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043987

Enrollment

120

Registered

2021-04-20

Start date

2021-04-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with histologically proven adenocarcinoma of the cecum, ascending colon, or right transverse colon cStage1-3 Patients scheduled to undergo laparoscopic or robotic ileoceacal resection, right hemicolectomy, or extended-right hemicolectomy Laparoscopic or robotic Overlap method is planned as a reconstruction method. Patients with preoperative ECOG PS 0-2 Patients aged 20 years or older at the time of enrollment Patients who have given written consent to participate in this study.

Exclusion criteria

Exclusion criteria: Patients with a history of multiple colorectal cancer requiring surgical resection Patients with concurrent multiple colorectal cancer requiring multiple anastomoses or resection sites Patients scheduled to undergo simultaneous other operation. Patients who cannot be pretreated due to preoperative bowel obstruction or severe stenosis Preoperative gastrointestinal perforation Pregnant, possibly pregnant, within 28 days postpartum, or breastfeeding. Patients who have psychosis or psychiatric symptoms that make it difficult to participate in the study. Patients receiving continuous systemic administration (intravenous or intravenous) of steroids or other immunosuppressive agents. Patients with serious comorbidities that are poorly controlled. Patients considered inappropriate by the physician in charge.

Design outcomes

Primary

Measure	Time frame
Incidence of anastomotic leakage	—

Countries

Japan

Contacts

Public ContactKeisuke Kazama

Yokohanma city university Departmnent of surgery

kkazama@yokohama-cu.ac.jp0457872800

Outcome results